• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Researchers raise funds for phase 1 trial to test medical cannabis in sickle cell disease


 

The Sickle Cell Foundation of Georgia (SCFG) has partnered with Biotech Research Laboratories and the Phoenix Tears Foundation to raise money for the first clinical study focused on the effectiveness of cannabis oil in sickle cell disease (SCD)-related pain management.

The initiative is in honor of World Sickle Cell Day, held annually on June 19 to mark the day the United Nations General Assembly recognized SCD as a public health problem.

“We urge the Sickle Cell community, our friends and allies to join in supporting the coalition as we search for alternative treatments for those battling this painful and sometimes fatal condition,” Deb McGhee McCrary, SCFG president and CEO, said in a news release. “These trials will fully explore the pain relief properties of medical cannabis as an alternative to highly addictive opioids.”

 

https://www.onescdvoice.com/wp-content/uploads/2018/08/cannabis.jpg

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close